3 min read
Evinature Co-Founder Nir Salomon, ChB, Sheds Light on CurQD Protocol in Live Interview with Aaron Blocker
Jun 29, 2025 - Evinature
Evinature co-founder Nir Salomon, ChB, joined IBD advocate Aaron Blocker in a live Instagram interview to discuss the science, personalization, and clinical success of the CurQD Protocol as a rigorous, physician-supported nutraceutical treatment for IBD.
Read more
2 min read
Evinature’s CurQD Protocol Presented at SickKids Hospital, Toronto
Jun 5, 2025- Evinature
Read more
2 min read
Evinature’s CurQD Protocol Presented at SickKids Hospital, Toronto
Jun 5, 2025- Evinature
Read more
2 min read
Evinature Featured at IBD Innovate 2025 for Advancing Gut Health Therapies
May 12, 2025 - Summer Pitocchelli-Schwartzman
The DDW Conference: Digestive Disease Week 2025 hosts medical professionals and researchers from every corner of gastroenterology and the world. At the biggest USA-based GI conference, Evinature co-founders presented CurQD® to hundreds of fascinated GI experts, pharmaceutical companies, and biotech enthusiasts alike with two posters displaying the latest and greatest CurQD® has to offer. Held […]
Read more